Ponatinib Iclusig Ponatinib Tablet
45,000 - 60,000 Per Box
Product Specifications Form Tablet Prescription/Non prescription Prescription Packaging Size Bottle of 30 Tablets Strength 45 mg Brand Iclusig Composition Ponatinib Treatment Cancer Deals in PCD Pharma Product Description Iclusig Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL).Iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy (1).This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with Iclusig
Post Free Ad
4.0